Exploring the role of aggrephagy-related signatures in immune microenvironment, prognosis, and therapeutic strategies of breast cancer

Chenbo Ye
DOI: https://doi.org/10.1097/md.0000000000039999
IF: 1.6
2024-10-30
Medicine
Abstract:Breast cancer (BC) constitutes a prevalent malignancy among women globally, accounting for an annual incidence rate of 11.67% among all newly diagnosed cancer cases, wherein it further contributes to 6.69% of total cancer fatalities annually. [ 1 ] Its complex etiology is characterized by a multifactorial interplay between genetic predispositions, hormonal influences, lifestyle factors, and environmental exposures. [ 2 ] The clinical course of BC can vary significantly, necessitating the development of more precise risk stratification models to guide personalized treatment strategies and improve patient outcomes. [ 3 ] Despite advances in early detection methods and therapeutic interventions, there remains a critical need for novel biomarkers and pathophysiological insights that could better predict disease progression, response to therapy, and overall survival. [ 4 ]
medicine, general & internal
What problem does this paper attempt to address?